Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Chongqing Medicine》 2017-17
Add to Favorite Get Latest Update

Study on effect of FTY720 combined with gecitabine on proliferation and apoptosis of non-small cell lung cancer tumor-related cell-lines

Qu Zhifeng;Xu Yuan;Wang Pei;Department of Radiotherapy,First Affiliated Hospital of Henan University of Science and Technology;  
Objective To investigate the effect of FTY720 and gemcitabine on the proliferation and apoptosis of H520 and A549 cells in non-small cell lung cancer(NSCLC)cell line.Methods The interventional influence on the in vitro cultured NSCLC A549 and H520 cells was performed by selecting 0,2,4,6,8,10 μmol/L concentrations of FTY720,then the absorbance value was detected at 24,48,72 hafter culture and the proliferation inhibiting effects of FTY720 on A549 and H520 were observed under the condition of different concentration of FTY720;adding single 7 μmol/L of FTY720,single 0.2 μmol/L gemcitabine and 37 μmol/L FTY720 combined with 0.2 mol/L gemcitabine into A549 and H520 cells lines,then the differences of inhibition and apoptosis after 48 hin the cells of each group were observed.Results The inhibitory effect of different concentrations of FTY270 on NSCLC A549 and H520 cell lines was statistically significant difference(P0.05).The proliferation inhibiting effect of FTY720 on NSCLC H520 and A549 cell lines had the correlation with the concentration and time.The apoptosis rate of FTY720 combined with gemcitabine on A549 and H520 cells was significantly higher than that of single use in these two drugs(P0.05).Conclusion FTY720 combined with gemcitabine can significantly inhibit the proliferation of A549 and H520 in human NSCLC,and can effectively promote the apoptosis of cancer cells,and has the higher clinical value.
【CateGory Index】: R734.2
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 8 Hits
1 Yu XIAO;Baoshan CAO;Li LIANG;Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital;;Nimotuzumab Significantly Enhances Chemosensitivity of PC9 Human Lung Adenocarcinoma Cells to Paclitaxel in vitro[J];中国肺癌杂志;2015-02
2 Lou Jun;Sheng Yu;Wu Minli;Tang Wanfen;Zhejiang JinHua Guangfu Hospital Internal Medicine-Oncology;;Correlation between human equilibrative nucleoside transporter 1 expression and chemotherapy sensitivity of gemcitabine and vinorelbine in patients with advanced non-small-cell carcinoma[J];中国医药;2015-02
3 LUO Tian-ying;Department of Respiratory Medicine,the People's Hospital of Macheng City;;Effect of thymopeptides α_1 on the immune function and CYFRA21-1 level in patients with non-smallcell lung carcinoma[J];新乡医学院学报;2015-02
4 TAN Wenhua;LIU Wei;WANG Ruixue;Department of Gynaecology and Obstetrics,the Second Hospital Affiliated to Harbin Medical University;;Effect and Mechanism of FTY720 on the Proliferation of Ovarian Cancer Cells[J];实用癌症杂志;2015-01
5 Lili QU;Xiaoqing LIU;Weixia WANG;Chuanhao TANG;Jianjie LI;Xiaoyan LI;Hongjun GAO;Xiaobing LI;Guangxian LIU;Department of Lung Cancer, the Affiliated Hospital of the Academy of Military Medical Science;Department of Pathology, the Affiliated Hospital of the Academy of Military Medical Science;Department of Hematology, the Affiliated Hospital of the Academy of Military Medical Science;;Expression and clinical significance of CN- Ⅱ in non-small cell lung cancer tissues[J];中国肿瘤临床;2015-01
6 Lou Jun;Sheng Yu;Ling Jin;Yuan Xiamei;Wu Minli;Tang Wanfen;Department of Internal MedicineOncology,Jinhua Guangfu Hospital,Zhejiang Province;;Observation of the clinical effect of different doses of gemcitabine chemotherapy for patients with high expression of human equilibrative nucleoside transporter 1 after advanced non-small-cell lung cancer operation[J];中国医药;2015-01
7 An Furong;Wang Shuping;Gui Xiaolong;Department of Pharmacy,Renji Hospital,School of Medicine,Shanghai Jiaotong University;;New First-line Treatment Drug for Advanced Non-small Cell Lung Cancer-Afatinib[J];中国药师;2015-01
8 LI Ying-Chun,LIU Zhuo-Gang,YAO Kun,WANG Hui-Han,Hu Rong,YANG Wei,LIAO Ai-Jun* Department of Hematology,Shenjing Hospital,China Medical University,Shenyang 110004,Liaoning Province,China;Mechanisms of ROS in U266 Cell Death Induced by FTY720[J];中国实验血液学杂志;2013-03
【Co-citations】
Chinese Journal Full-text Database 8 Hits
1 ZHANG Zonglin;ZHANG Bo;ZHAO Liangliang;WANG Fang;ZHANG Guimin;Linyi People's Hospital;National Engineering and Technology Research Center of Chirality Pharmaceutical, Lunan Pharmaceutical Group Co.,Ltd.;;Determination of the Related Substances of Afatinib by UPLC[J];中国医药工业杂志;2017-10
2 Li Haiqiong;Guangxi Hospital of Liu Gang;;Research Progress of Afatinib for Treating Non-Small Cell Lung Cancer[J];中国药业;2017-19
3 Qu Zhifeng;Xu Yuan;Wang Pei;Department of Radiotherapy,First Affiliated Hospital of Henan University of Science and Technology;;Study on effect of FTY720 combined with gecitabine on proliferation and apoptosis of non-small cell lung cancer tumor-related cell-lines[J];重庆医学;2017-17
4 CHEN Xiao-hua;GONG Hui-li;QIU Xiao-ping;Pharmacy, the Pulmonary Hospital of Pudong New Area;Department of Respiratory, the Pulmonary Hospital of Pudong New Area;Department of Oncology, the People's Hospital of Pudong New Area Shanghai;;Collaborative action research of azole phosphonic acid and gemcitabine for the treatment of non-small cell lung cancer[J];海南医学;2017-11
5 WANG Ming-yuan;TANG Xiao-han;LU Mei-song;Department of Obstetrics and Gynecology,The First Hospital of Harbin Medical University;;Research Progress of Common Gynecologic Malignancy in the Autophagy[J];国际妇产科学杂志;2017-01
6 Hu Tingting;Gong Qiaoyan;Xu Ting;Department of Pharmacy,West China Hospital,Sichuan University;;Transformation of Non-small Cell Lung Cancer to Small Cell Lung Cancer after EGFR-TKI Resistance in Two Patients[J];中国药师;2016-12
7 LI Hongjuan;YANG Jun;JIANG Ying;GE Weihong;College of Pharmaceutical Science,Zhejiang Chinese Medical University;Medical School,Hangzhou Normal University;Suzhou Biological Technology Co.Ltd.of Centre Testing International Corporation;;Effects of Shenmai Injection on Proliferation and Apoptosis of p53-deficient Hep3B Cells[J];中华中医药学刊;2016-10
8 KUANG Shu-gen;LIU Xia;LIU Tie-bing;ZHANG Shi;WEN Qin-sheng;Department of Oncology,Xiushui County the First People′s Hospital of Jiujiang City in Jiangxi Province;;Effect observation of Cisplatin and Docetaxel in the treatment of patients with non small cell lung cancer[J];中国当代医药;2016-26
【Secondary Citations】
Chinese Journal Full-text Database 10 Hits
1 WANG Cui-jun;Department of Oncology,Linxi Hospital of Kailuan General Hospital;;Effect of surgery combined with chemotherapy on nonsmall-cell lung cancer[J];新乡医学院学报;2014-06
2 ZHANG Hua-ji;GUO Shu-jin;SUN Ling;WEN Qing-hui;CHENG Bao;Information Center of State Food and Drug Administration;;Brief analysis on new drugs approved by FDA in 2013[J];中国新药杂志;2014-06
3 FU Li-ping;ZHANG Yu-fen;ZHANG Rong-ze;Department of Cardiothoracic Surgery,Fourth Affiliated Hospital of Hebei Medical University;;Effect of emotional and psychological intervention on the life quality of patients with advanced lung cancer[J];中国肿瘤临床与康复;2014-04
4 ZHAO Leilei;ZHANG Yuan;ZHOU Jinpei;ZHANG Huibin;Center of Drug Discovery,China Pharmaceutical University;;Advances in research on drugs targeting non-small cell lung cancer[J];中国药科大学学报;2014-02
5 CAI Peng;CHEN Gui-ming;YANG Xian-guo;The First Department of Oncology,the Second People's Hospital of Jingmen City;;Effects of thymosin α1 on immune function in patients with non-small cell lung cancer treated by chemotherapy[J];中国肿瘤临床与康复;2014-03
6 ;afatinib[J];中国药物化学杂志;2014-01
7 CAI Zhi-hui;ZHANG Cui-ying;Departmennt of Medical Oncology,Inner Mongolia Hospital;;Advance in targeted therapies for lung cancer[J];西部医学;2014-01
8 PENG Ye;ZHANG Xugang;XIE Na;WANG Meigin;LI Bingmao;Department of Oncology,Harrison International Peace Hospital;;Clinical observation on therapeutic effect of thalidomide in combination with paclitaxel plus cisplatin regimen in the treatment of elderly patients with advanced non-small cell lung cancer[J];疑难病杂志;2014-01
9 LIN Li-ping;HU Jia-zhu;HUANG Fu-xi;LI Wei-zhan;LI Xiu-yue;HAN Jian-jun;CAO Xiao-long;Department of Oncology, Central Hospital of Panyu;;Comparison of gemcitabine combined with chemotherapy and other regimens in the treatment of advancednon-small cell lung cancer[J];海南医学;2014-01
10 ZHANG Bei-bei;SONG Zheng-bo;HE Chun-xiao;Zhejiang Cancer Hospital,Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology(Lung and Esophagus);;Clinical Analysis of Gemcitabine with Two Dose Levels Plus Carboplatin in the First-line Treatment for Advanced Nonsmall Cell Lung Cancer[J];肿瘤学杂志;2013-12
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved